Samsung Biologics R Rights (2079401G)
2079401G · Health Care · 
Korea
Samsung Biologics R Rights (2079401G) is a South Korean company in the Health Care sector. Anyone who holds an ETF containing Samsung Biologics R Rights also has an indirect stake in the company.
Data and Charts: Samsung Biologics R Rights
Key Data for Samsung Biologics R Rights
Alysly Data Analysis: Samsung Biologics R Rights
What ETF Is Samsung Biologics R Rights In?
Samsung Biologics R Rights has below-average ETF coverage and is held by 2 of the 104 ETFs we track, which together follow 2 indices. That puts the stock in more ETFs than 21.9% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IUSQ | MSCI ACWI | < 0.01% | < €0.05 |
| IS3N | MSCI EM IMI | < 0.01% | < €0.05 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Samsung Biologics R Rights as of the fund's latest holdings list.
To see how much Samsung Biologics R Rights overlaps with other holdings in a portfolio, use What's Inside Your ETF Portfolio or the ETF overlap check.
Stocks With ETF Exposure Similar to Samsung Biologics R Rights
| Stock | Shared ETFs | r |
|---|---|---|
| Samsung Biologics R Rights | – | – |
| SK | 2 | – |
| Lig Defense&Aerospace | 2 | – |
| Amorepacific | 2 | – |
| The Peoples Insurance Co (Group) | 2 | – |
| Commercial International Bank | 2 | – |
| CP All Non-Voting DR | 2 | – |
| Delta Electronics (Thailand) | 2 | – |
 Gazprom | 2 | – |
These stocks reach a portfolio through largely the same funds as Samsung Biologics R Rights. “Shared ETFs” counts the funds that hold both.
